Amir Dori

1.7k total citations
66 papers, 1.1k citations indexed

About

Amir Dori is a scholar working on Molecular Biology, Neurology and Pharmacology. According to data from OpenAlex, Amir Dori has authored 66 papers receiving a total of 1.1k indexed citations (citations by other indexed papers that have themselves been cited), including 27 papers in Molecular Biology, 19 papers in Neurology and 11 papers in Pharmacology. Recurrent topics in Amir Dori's work include Cholinesterase and Neurodegenerative Diseases (11 papers), Blood Coagulation and Thrombosis Mechanisms (9 papers) and Botulinum Toxin and Related Neurological Disorders (8 papers). Amir Dori is often cited by papers focused on Cholinesterase and Neurodegenerative Diseases (11 papers), Blood Coagulation and Thrombosis Mechanisms (9 papers) and Botulinum Toxin and Related Neurological Disorders (8 papers). Amir Dori collaborates with scholars based in Israel, United States and France. Amir Dori's co-authors include Hermona Soreq, Efrat Shavit‐Stein, Joab Chapman, Eran Meshorer, Debra Toiber, Nicola Maggio, Jonathan Cohen, Chaya Brodie, Simona Cazacu and Gila Kazimirsky and has published in prestigious journals such as Journal of Biological Chemistry, Nature Communications and The EMBO Journal.

In The Last Decade

Amir Dori

57 papers receiving 1.0k citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Amir Dori Israel 17 460 236 228 200 155 66 1.1k
Paul Thornhill United Kingdom 8 560 1.2× 132 0.6× 327 1.4× 245 1.2× 311 2.0× 8 1.5k
Giuseppe Muraca Italy 8 402 0.9× 83 0.4× 153 0.7× 176 0.9× 260 1.7× 9 872
Jing Xiong China 17 419 0.9× 136 0.6× 221 1.0× 168 0.8× 216 1.4× 45 1.1k
Annamaria Confaloni Italy 21 665 1.4× 105 0.4× 239 1.0× 161 0.8× 480 3.1× 59 1.4k
Katalin Majtényi Hungary 14 402 0.9× 85 0.4× 464 2.0× 236 1.2× 391 2.5× 26 1.2k
Houng‐Chi Liou Taiwan 21 546 1.2× 133 0.6× 142 0.6× 160 0.8× 217 1.4× 30 1.2k
Yafang Zhou China 20 437 0.9× 44 0.2× 224 1.0× 200 1.0× 267 1.7× 64 1.1k
Patrick L. McGeer Canada 12 392 0.9× 110 0.5× 97 0.4× 163 0.8× 511 3.3× 13 1.0k
Hisatomo Kowa Japan 16 275 0.6× 57 0.2× 308 1.4× 189 0.9× 353 2.3× 69 895
Parichehr Pasbakhsh Iran 21 372 0.8× 77 0.3× 111 0.5× 226 1.1× 213 1.4× 78 1.3k

Countries citing papers authored by Amir Dori

Since Specialization
Citations

This map shows the geographic impact of Amir Dori's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Amir Dori with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Amir Dori more than expected).

Fields of papers citing papers by Amir Dori

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Amir Dori. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Amir Dori. The network helps show where Amir Dori may publish in the future.

Co-authorship network of co-authors of Amir Dori

This figure shows the co-authorship network connecting the top 25 collaborators of Amir Dori. A scholar is included among the top collaborators of Amir Dori based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Amir Dori. Amir Dori is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Dori, Amir, et al.. (2024). Cross-species modeling of muscular dystrophy in Caenorhabditis elegans using patient-derived extracellular vesicles. Disease Models & Mechanisms. 17(3). 1 indexed citations
2.
Gentile, Luca, Igor Diemberger, Violaine Planté‐Bordeneuve, et al.. (2024). Phenotypic characteristics of F64L, I68L, I107V, and S77Y ATTRv genotypes from the Transthyretin Amyloidosis Outcomes Survey (THAOS). PLoS ONE. 19(1). e0292435–e0292435. 2 indexed citations
3.
Dori, Amir, Michael Arad, Yishay Wasserstrum, et al.. (2023). Ser77Tyr transthyretin amyloidosis in Israel: Initial manifestations and diagnostic features. Annals of Clinical and Translational Neurology. 10(4). 553–567. 3 indexed citations
4.
Gomel, Nir, et al.. (2023). Müller's Muscle as a Sensory Proprioceptive Organ: Histological and Histochemical Analysis. Investigative Ophthalmology & Visual Science. 64(5). 18–18. 2 indexed citations
5.
Goldberg, Zehavit, Amir Dori, Nicola Maggio, et al.. (2023). PARIN5, a Novel Thrombin Receptor Antagonist Modulates a Streptozotocin Mice Model for Diabetic Encephalopathy. International Journal of Molecular Sciences. 24(3). 2021–2021. 1 indexed citations
6.
Kaplan, Batia, Olga Kukuy, Michael Arad, et al.. (2023). Diagnostic Challenges and Solutions in Systemic Amyloidosis. International Journal of Molecular Sciences. 24(5). 4655–4655. 4 indexed citations
7.
Pepys, J., Guy Ben‐Betzalel, Ronnie Shapira‐Frommer, et al.. (2023). Incidence and Outcome of Neurologic Immune-Related Adverse Events Associated With Immune Checkpoint Inhibitors in Patients With Melanoma. Neurology. 101(24). e2472–e2482. 13 indexed citations
8.
Goldberg, Zehavit, et al.. (2022). LPS-Induced Coagulation and Neuronal Damage in a Mice Model Is Attenuated by Enoxaparin. International Journal of Molecular Sciences. 23(18). 10472–10472. 9 indexed citations
9.
Magen, Eli, Sumit Mukherjee, Eugene Merzon, et al.. (2022). Clinical and Molecular Characterization of a Rare Case of BNT162b2 mRNA COVID-19 Vaccine-Associated Myositis. Vaccines. 10(7). 1135–1135. 15 indexed citations
10.
Dori, Amir, et al.. (2022). Thrombin Activity in Rodent and Human Skin: Modified by Inflammation and Correlates with Innervation. Biomedicines. 10(6). 1461–1461. 2 indexed citations
11.
Shavit‐Stein, Efrat, et al.. (2022). Modulation of the Thrombin Pathway Restores LTP in a Pilocarpine Mice Model of Status Epilepticus. Frontiers in Cellular Neuroscience. 16. 900925–900925. 2 indexed citations
12.
Chapman, Joab, et al.. (2021). Complement and Coagulation System Crosstalk in Synaptic and Neural Conduction in the Central and Peripheral Nervous Systems. Biomedicines. 9(12). 1950–1950. 21 indexed citations
13.
Shavit‐Stein, Efrat, et al.. (2021). Prolonged Systemic Inflammation Alters Muscarinic Long-Term Potentiation (mLTP) in the Hippocampus. Neural Plasticity. 2021. 1–6. 5 indexed citations
14.
Altman, Topaz, Ariel Ionescu, Elizabeth M.H. Tank, et al.. (2021). A CRMP4‐dependent retrograde axon‐to‐soma death signal in amyotrophic lateral sclerosis. The EMBO Journal. 40(17). e107586–e107586. 11 indexed citations
15.
Shavit‐Stein, Efrat, et al.. (2020). Treatment of Diabetic Neuropathy with A Novel PAR1-Targeting Molecule. Biomolecules. 10(11). 1552–1552. 9 indexed citations
16.
Shavit‐Stein, Efrat, Roni Sharon, Lea Pollak, et al.. (2020). Brain Protease Activated Receptor 1 Pathway: A Therapeutic Target in the Superoxide Dismutase 1 (SOD1) Mouse Model of Amyotrophic Lateral Sclerosis. International Journal of Molecular Sciences. 21(10). 3419–3419. 11 indexed citations
17.
Shavit‐Stein, Efrat, et al.. (2019). The role of thrombin in the pathogenesis of diabetic neuropathy. PLoS ONE. 14(7). e0219453–e0219453. 13 indexed citations
18.
Shavit‐Stein, Efrat, et al.. (2016). Thrombin and protein C pathway in peripheral nerve Schwann cells. Neuroscience. 339. 587–598. 20 indexed citations
19.
Dori, Amir, Gal Ifergane, Marina Bersudsky, et al.. (2007). Readthrough acetylcholinesterase in inflammation-associated neuropathies. Life Sciences. 80(24-25). 2369–2374. 9 indexed citations
20.
Meshorer, Eran, Debra Toiber, Jonathan Cohen, et al.. (2005). SC35 promotes sustainable stress-induced alternative splicing of neuronal acetylcholinesterase mRNA. Molecular Psychiatry. 10(11). 985–997. 73 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Paul Thornhill Breakdown of academic impact, for papers by Giuseppe Muraca Breakdown of academic impact, for papers by Jing Xiong Breakdown of academic impact, for papers by Annamaria Confaloni Breakdown of academic impact, for papers by Katalin Majtényi Breakdown of academic impact, for papers by Houng‐Chi Liou Breakdown of academic impact, for papers by Yafang Zhou Breakdown of academic impact, for papers by Patrick L. McGeer Breakdown of academic impact, for papers by Hisatomo Kowa Breakdown of academic impact, for papers by Parichehr Pasbakhsh
Rankless by CCL
2026